← Evidence map

TrialBlood2016

The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib.

Wendy T Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26773037